Glucose dysmetabolism and prognosis in critical illness

Internal and Emergency Medicine

Volumn 4, Issue 2, 2009, Pages 147-156

  Lazzeri, Chiara ^a   Tarquini, Roberto ^c   Giunta, Francesco ^b   Gensini, Gian Franco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Critical illness; Hyperglycemia; Insulin resistance

Indexed keywords

ARTICLE; CRITICAL ILLNESS; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; METABOLISM; PROGNOSIS;

CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; PROGNOSIS;

EID: 62949224803     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-008-0206-3     Document Type: Article

References (73)

1. KC McCowen A Malhotra BR Bistrian 2001 Stress-induced hyperglycemia Crit Care Clin 17 107 124
2. CH Lang C Dobrescu GJ Bagby 1992 Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output Endocrinology 130 43 52
3. L Lind H Lithell 1994 Impaired glucose and lipid metabolism seen in intensive care patients is related to severity of illness and survival Clin Intensive Care 5 100 105
4. AG Pittas RD Siegel J Lau 2004 Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials Arch Intern Med 164 2005 2011
5. JJ Ligtenberg S Meijering Y Stienstra IC van der Horst M Vogelzang MW Nijsten JE Tulleken JG Zijlstra 2006 Mean glucose level is not an independent risk factor for mortality in mixed ICU patients Intensive Care Med 32 435 438
6. BA Mizock 2001 Alterations in fuel metabolism in critical illness: hyperglycaemia Best Pract Res Clin Endocrinol Metab 15 533 551
7. A Klip T Tsakiridis A Marette PA Ortiz 1994 Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures FASEB J 8 43 53
8. L Langouche G Van den Berghe 2006 Glucose metabolism and insulin therapy Crit Care Clin 22 119 129
9. S Khani JA Tayek 2001 Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome Clin Sci (Lond) 101 739 747
10. MJ Watt KF Howlett MA Febbraio LL Spriet M Hargreaves 2001 Adrenaline increases skeletal muscle glycogenolysis, pyruvate dehydrogenase activation and carbohydrate oxidation during moderate exercise in humans J Physiol 534 Pt 1 269 278
11. KJ Rodnick RC Piper JW Slot DE James 1992 Interaction of insulin and exercise on glucose transport in muscle Diabetes Care 15 1679 1689 Review
12. G Van den Berghe 2004 How does blood glucose control with insulin save lives in intensive care? J Clin Invest 114 1187 1195
13. LA Quinn WD McCumbee 1998 Regulation of glucose transport by angiotensin II and glucose in cultured vascular smooth muscle cells J Cell Physiol 177 94 102
14. M Brownlee 2001 Biochemistry and molecular cell biology of diabetic complications Nature 414 6865 813 820
15. I Vanhorebeek R De Vos D Mesotten PJ Wouters C De Wolf-Peeters G Van den Berghe 2005 Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients Lancet 365 9453 53 59
16. G van den Berghe P Wouters F Weekers C Verwaest F Bruyninckx M Schetz D Vlasselaers P Ferdinande P Lauwers R Bouillon 2001 Intensive insulin therapy in critically ill patients N Engl J Med 345 1359 1367
17. G Van den Berghe PJ Wouters R Bouillon F Weekers C Verwaest M Schetz D Vlasselaers P Ferdinande P Lauwers 2003 Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control Crit Care Med 31 359 366
18. IB Hirsch M Brownlee 2005 Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 19 178 181
19. AM Corstjens IC van der Horst JG Zijlstra AB Groeneveld F Zijlstra JE Tulleken JJ Ligtenberg 2006 Hyperglycaemia in critically ill patients: marker or mediator of mortality? Crit Care 10 216
20. GE Umpierrez SD Isaacs N Bazargan X You LM Thaler AE Kitabchi 2002 Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes J Clin Endocrinol Metab 87 978 982
21. CM Cely P Arora AA Quartin DH Kett RM Schein 2004 Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness Chest 126 879 887
22. C Christiansen P Toft HS Jørgensen SK Andersen E Tønnesen 2004 Hyperglycaemia and mortality in critically ill patients. A prospective study Intensive Care Med 30 1685 1688
23. JS Krinsley 2003 Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients Mayo Clin Proc 78 1471 1478
24. BW Whitcomb EK Pradhan AG Pittas MC Roghmann EN Perencevich 2005 Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations Crit Care Med 33 2772 2777
25. NN Wahab EA Cowden NJ Pearce MJ Gardner H Merry JL Cox 2002 ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 40 1748 1754
26. G Giannazzo F Tola S Vanni E Bondi G Pepe S Grifoni 2006 Prognostic indexes of septic syndrome in the emergency department Intern Emerg Med 1 229 233
27. KM Ban P Rosen 2006 Sepsis and its consequences Intern Emerg Med 1 221 222
28. Krentz AJ, Natrass M (1997) Acute metabolic complications of diabetes mellitus: diabetic ketoacidosis, hyperosmolar non-ketotic syndrome and lactic acidosis. In: Pickup JC, Williams G (eds) Textbook of diabetes, 2nd edn. Blackwell, Oxford, pp 1-23
29. M Al-Mallah O Zuberi M Arida HE Kim 2008 Positive troponin in diabetic ketoacidosis without evident acute coronary syndrome predicts adverse cardiac events Clin Cardiol 31 67 71
30. J Bolk T van der Ploeg JH Cornel AE Arnold J Sepers VA Umans 2001 Impaired glucose metabolism predicts mortality after a myocardial infarction Int J Cardiol 79 207 214
31. SE Capes D Hunt K Malmberg HC Gerstein 2000 Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview Lancet 355 9206 773 778
32. I Stranders M Diamant RE van Gelder HJ Spruijt JW Twisk RJ Heine FC Visser 2004 Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus Arch Intern Med 164 982 988
33. Ainla T, Baburin A, Teesalu R, Rahu M (2005) The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes. Diabet Med 1321-1325
34. D Aronson H Hammerman MR Kapeliovich A Suleiman Y Agmon R Beyar W Markiewicz M Suleiman 2007 Fasting glucose in acute myocardial infarction: incremental value for long-term mortality and relationship with left ventricular systolic function Diabetes Care 30 960 966
35. Müdespacher D, Radovanovic D, Camenzind E, Essig M, Bertel O, Erne P, Eberli FR, Gutzwiller F (2007) On Behalf Of The Amis Plus Investigators. Admission glycaemia and outcome in patients with acute coronary syndrome. Diab Vasc Dis Res 346-52
36. LS Williams J Rotich R Qi N Fineberg A Espay A Bruno SE Fineberg WR Tierney 2002 Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke Neurology 59 67 71
37. SE Capes D Hunt K Malmberg P Pathak HC Gerstein 2001 Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview Stroke 32 2426 2432
38. S Yendamuri GJ Fulda GH Tinkoff 2003 Admission hyperglycemia as a prognostic indicator in trauma J Trauma 55 33 38
39. TM Duane RR Ivatury T Dechert H Brown LG Wolfe AK Malhotra MB Aboutanos 2008 Blood glucose levels at 24 hours after trauma fails to predict outcomes J Trauma 64 1184 1187
40. WL Wahl M Taddonio PM Maggio S Arbabi MR Hemmila 2008 Mean glucose values predict trauma patient mortality J Trauma 65 42 47
41. SI Brundage NN Kirilcuk JC Lam DA Spain NA Zautke 2008 Insulin increases the release of proinflammatory mediators J Trauma 65 367 372
42. M Vogelzang JM Nijboer IC van der Horst F Zijlstra HJ ten Duis MW Nijsten 2006 Hyperglycemia has a stronger relation with outcome in trauma patients than in other critically ill patients J Trauma 60 873
43. G Van den Berghe K Schoonheydt P Becx F Bruyninckx PJ Wouters 2005 Insulin therapy protects the central and peripheral nervous system of intensive care patients Neurology 64 1348 1353
44. JS Krinsley 2004 Effect of an intensive glucose management protocol on the mortality of critically ill adult patients Mayo Clin Proc 79 992 1000
45. G Van den Berghe A Wilmer I Milants PJ Wouters B Bouckaert F Bruyninckx R Bouillon M Schetz 2006 Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm Diabetes 55 3151 3159
46. K Malmberg A Norhammar H Wedel L Ryden 1999 Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study Circulation 99 2626 2632
47. SR Mehta S Yusuf R Diaz J Zhu P Pais D Xavier E Paolasso R Ahmed C Xie K Kazmi J Tai A Orlandini J Pogue L Liu 2005 CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: The CREATE-ECLA randomized controlled trial. CREATE-ECLA Trial Group Investigators JAMA 293 437 446
48. K Malmberg L Ryden H Wedel K Birkeland A Bootsma K Dickstein S Efendic M Fisher A Hamsten J Herlitz P Hildebrandt K MacLeod M Laakso C Torp-Pedersen A Waldenström 2005 DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity Eur Heart J 26 650 661
49. K Malmberg L Ryden A Hamsten J Herlitz A Waldenström H Wedel 1996 Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction: DIGAMI Study Group. Diabetes Insulin- Glucose in Acute Myocardial Infarction Eur Heart J 17 1337 1344
50. K Malmberg 1997 Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus: DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group BMJ 314 1512 1515
51. K Malmberg L Rydén S Efendic J Herlitz P Nicol A Waldenström H Wedel L Welin 1995 Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year J Am Coll Cardiol 26 57 65
52. JF Scott GM Robinson JM French JE O'Connell KG Alberti CS Gray 1999 Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: The Glucose Insulin in Stroke Trial (GIST) Stroke 30 793 799
53. FM Brunkhorst C Engel F Bloos A Meier-Hellmann M Ragaller N Weiler O Moerer M Gruendling M Oppert S Grond D Olthoff U Jaschinski S John R Rossaint T Welte M Schaefer P Kern E Kuhnt M Kiehntopf C Hartog C Natanson M Loeffler K Reinhart 2008 German Competence Network Sepsis (SepNet). (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis N Engl J Med 358 125 139
54. JS Krinsley RL Jones 2006 Cost analysis of intensive glycemic control in critically ill adult patients Chest 129 644 650
55. NJ Grey GA Perdrizet 2004 Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control Endocr Pract Suppl 2 46 52
56. Mesotten D, Swinnen J, Vanderhoydonc F, Wouters PJ, Van den Berghe G (2004) Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 219-226
57. PO Kwiterovich 2002 Lipoprotein heterogeneity: diagnostic and therapeutic implications Am J Cardiol 90 1i 10i
58. Feingold KR, Krauss RM, Pang M, Doerrler W, Jensen P, Grunfeld C (1993) The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J Clin Endocrinol Metab 1423-1427
59. Harris HW, Grunfeld C, Feingold KR, Read TE, Kane JP, Jones AL, Eichbaum EB, Bland GF, Rapp JH (1993) Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 1028-1034
60. Harris HW, Grunfeld C, Feingold KR, Rapp JH (1990) Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 696-702
61. TN Tulenko AE Sumner 2002 The physiology of lipoproteins J Nucl Cardiol 9 638 649
62. RH Bartlett RE Dechert JR Mault SK Ferguson AM Kaiser EE Erlandson 1982 Measurement of metabolism in multiple organ failure Surgery 92 771 779
63. DC Gore DL Chinkes DW Hart SE Wolf DN Herndon AP Sanford 2002 Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients Crit Care Med 30 2438 2442
64. F Weekers E Van Herck W Coopmans M Michalaki CY Bowers JD Veldhuis G Van den Berghe 2002 A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response Endocrinology 143 764 774
65. B Collier LA Dossett AK May JJ Diaz 2008 Glucose control and the inflammatory response Nutr Clin Pract 23 3 15
66. TK Hansen S Thiel PJ Wouters JS Christiansen G van den Berghe 2003 Intensive insulin therapy exerts anti-inflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels J Clin Endocrinol Metab 88 1082 1088
67. P Dandona K Thusu R Hafeez E Abdel-Rahman A Chaudhuri 1998 Effect of hydrocortisone on oxygen free radical generation by mononuclear cells Metabolism 47 788 791
68. L Langouche I Vanhorebeek D Vlasselaers S Vander Perre PJ Wouters K Skogstrand TK Hansen G Van den Berghe 2005 Intensive insulin therapy protects the endothelium of critically ill patients J Clin Invest 115 2277 2286
69. Gao F, Gao E, Yue TL, Ohlstein EH, Lopez BL, Christopher TA, Ma XL (2002) Nitric oxide mediates the anti-apoptotic effect of insulin in myocardial ischemia- reperfusion: the role of PI3-kinase, Akt, and eNOS phosphorylation. Circulation 1497-1502
70. A Jonassen M Sack O Mjos D Yellon 2001 Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signalling Circ Res 89 1191 1198
71. A Jonassen E Aasum R Riemersma O Mjos T Larsen 2000 Glucose-insulin- potassium reduces infarct size when administered during reperfusion Cardiovasc Drugs Ther 14 615 623
72. SJ Finney C Zekveld A Elia TW Evans 2003 Glucose control and mortality in critically ill patients JAMA 290 2041 2047
73. B Ellger Y Debaveye I Vanhorebeek L Langouche A Giulietti E Van Etten P Herijgers C Mathieu G Van den Berghe 2006 Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin Diabetes 55 1096 1105